Selective COX-2 inhibitor. Stomach protection--but not always
MMW Fortschritte der Medizin 143(25): 60
2001
ISSN/ISBN: 1438-3276 PMID: 11469005 Document Number: 538215
Document emailed within 1 workday
Related Documents
Muraki, I. 2001: Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate Hokkaido Journal of Medical Science 76(2): 57-70Hettich, M.; Thomae, K. 1997: Selective cyclooxygenase-2 inhibitor Der Internist 38(10): 1007
Hasselbalch, H.C.; Mourits-Andersen, H.T.; Jensen, B.A.; Nielsen, O.J. 1996: Anagrelide. a selective inhibitor of thrombopoiesis Ugeskrift for Laeger 158(12): 1693-1695
Tkachuk, V.A.; Baldenkov, G.N.; Feoktistov, I.A.; Men'shikov, M.Y.; Quast, U.; Herzig, J.W. 1987: Metofenazate as a more selective calmodulin inhibitor than trifluoperazine Arzneimittel-Forschung 37(9): 1013-1017
Goss, P.E.; Tye, L.M. 1997: Anastrozole: a new selective nonsteroidal aromatase inhibitor Oncology 11(11): 1697-1703; Discussion: 1707-1708
Smedegaard, J.; Christiansen, P.; Skrumsager, B. 1981: "Treatment of obesity by femoxetine a selective 5 HT reuptake inhibitor' International Journal of Obesity 5(4): 377-378
Arcimowicz, M.; Samoliński, B.ła.; Gotlib, T.; Nyckowska, J. 2002: Nimesulide (Aulin)--the selective COX-2 inhibitor in the treatment of ENT diseases Otolaryngologia Polska 56(4): 501-507
Matijasevic, Z. 2002: Selective protection of non-cancer cells by hypothermia Anticancer Research 22(6a): 3267-3272
Najda, J.; Stella-Hołowiecka, B. 2005: Clinical application of anagrelide as a selective inhibitor of megakaryocyte system Wiadomosci Lekarskie 58(11-12): 665-669
Alessandri, C.; Peverini, F. 1992: Clinical evaluation of a selective inhibitor of cholesterol synthesis: pravastatin Minerva Medica 83(11): 677-693
Pacher, P.ál.; Kecskeméti, V.ér. 2004: Cardiovascular effects of selective serotonin reuptake inhibitor antidepressants Orvosi Hetilap 145(8): 425-431
Laudanno, O.M.; Piombo, G.; Cesolari, J.A.M.; Godoy, A.; Rocaspana, A.; Aramberry, L. 2002: Dexketoprofene, selective cox-1 inhibitor nsaids, without gastrointestinal injury in rats Acta Gastroenterologica Latinoamericana 32(1): 17-20
Kagaya, T.; Kajiwara, A.; Nagato, S.; Akasaka, K.; Kubota, A. 1996: E2011 a novel, selective and reversible inhibitor of monoamine oxidase type a Journal of Pharmacology and Experimental Therapeutics 278(1): 243-251
Kawamoto, S.; Hidaka, H. 1984: 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets Biochemical and Biophysical Research Communications 125(1): 258-264
Floridi, A.; Paggi, M.G.; Marcante, M.L.; Silvestrini, B.; Caputo, A.; De Martino, C. 1981: Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells Journal of the National Cancer Institute 66(3): 497-499
Okamoto, S.; Yonekawa, Y.; Handa, H.; Handa, Y.; Uemura, Y.; Yano, I.; Toyoshima, M.; Iwatsuji, K.; Teraura, T.; Yamagata, S. 1986: Treatment of occlusive cerebrovascular disease with a selective thromboxane A2 synthetase inhibitor Nihon Geka Hokan. Archiv für Japanische Chirurgie 55(1): 251-259
Niwa, T.; Maeda, K.; Shibata, M.; Yamada, K. 1988: Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome Clinical Nephrology 30(5): 276-281
Read, G.W.; Kiefer, E.F. 1979: Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines Journal of Pharmacology and Experimental Therapeutics 211(3): 711-715
Kawata, K.; Takeyoshi, I.; Iwanami, K.; Sunose, Y.; Tsutsumi, H.; Ohwada, S.; Matsumoto, K.; Morishita, Y. 2003: The effects of a selective cyclooxygenase-2 inhibitor on small bowel ischemia-reperfusion injury Hepato-Gastroenterology 50(54): 1970-1974
Kostrubsky, V.E.; Szakacs, J.G.; Jeffery, E.H.; Woods, S.G.; Bement, W.J.; Wrighton, S.A.; Sinclair, P.R.; Sinclair, J.F. 1997: Protection of ethanol-mediated acetaminophen hepatotoxicity by triacetyloleandomycin, a specific inhibitor of CYP3A Annals of Clinical and Laboratory Science 27(1): 57-62